TP53 and neoplasm: This dual interaction, particularly in the context of disrupted wild-type P53 and accumulation of mutant P53, facilitates STAT3-driven support for tumor cell proliferation and survival (Dodd et al. 2015; Schulz-Heddergott, et al. 2018).